Cerebras Systems

The stock of Cerebras Systems fell intraday by about 2.4% to $210.50 after the company unveiled the AI accelerator system CS-4 and a partnership with OpenAI at Supernova Day. Traders are taking profits after the pre-event price run-up, and the shares were further weighed down by an increase in the freely tradable float of roughly 36.4 million shares around August 14. Management warned it may need to rent back compute capacity in the short term, which could temporarily pressure gross margins. Analyst views are mixed (Morgan Stanley and Rosenblatt reaffirm buy ratings, while Citi and Mizuho cut price targets), and the rate-sensitive market environment is adding pressure on growth names like CBRS. » More on de.investing.com

At Supernova 2026, Cerebras presented the CS-4 system on the Nexus platform, which the company says delivers up to 30× faster inference on Frontier models than GPU solutions and twice as many tokens per second as the CS-3. In collaboration with OpenAI, Cerebras introduced the GPT-5.6 Sol Ultrafast mode, which runs models up to 14× faster; early-access tests and selected customer projects are already under way. The company reported more than 600 MW of contractually committed data-center capacity, new partnerships (including AMD, Arista, AWS) and a roadmap to CS-5 (2027) with annual performance doubling. The stock fell sharply in regular trading but recovered slightly in after-hours trading. » More on de.investing.com

After a strong price rally, selling pressure returned to Cerebras following a Wedbush report that identified the company as the compute partner for OpenAI’s new Ultrafast mode of GPT-5.6 Sol. Wedbush cites a commitment to procure 750 MW by 2028 and a multi‑year supply agreement worth $20 billion, plus $1 billion in data‑center financing. The stock also reacted to quarterly results showing strong revenue growth (GAAP revenue +74%, non‑GAAP core revenue +103%) and a GAAP net loss of $450.5 million; Cerebras raised its full‑year 2026 guidance and reports open order commitments of $25.4 billion. Several analysts reaffirm buy ratings with median price targets around $299, but the stock remains highly volatile. » More on finanzen.net